A GPI‐anchored co‐receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression
Open Access
- 6 April 2006
- journal article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 4 (5), 1114-1124
- https://doi.org/10.1111/j.1538-7836.2006.01873.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Comparison of cell-surface TFPIα and βJournal of Thrombosis and Haemostasis, 2005
- Glycosyl Phosphatidylinositol Anchorage of Tissue Factor Pathway InhibitorCirculation, 2003
- Dissecting and manipulating the pathway for glycosylphos-phatidylinositol-anchor biosynthesisCurrent Opinion in Chemical Biology, 2000
- Reversible Regulation of Tissue Factor–Induced Coagulation by Glycosyl Phosphatidylinositol–Anchored Tissue Factor Pathway InhibitorArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Tissue Factor Pathway Inhibitor in Endothelial Cells Colocalizes With Glycolipid Microdomains/CaveolaeArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitorBiochemical Journal, 1997
- Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.The Journal of cell biology, 1996
- Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitorBiochemical Journal, 1994
- The C-terminus of tissue factor pathway inhibitor (TFPI) is essential to its anticoagulant activityBiochemistry, 1991
- Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitorNature, 1989